NEXT is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
NEXT has participated in 119 clinical trials with 92 currently active.
Therapeutic areas: KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant Colorectal Cancer (CRC).
Sponsors: Kestrel Therapeutics, Inc., Inmune Bio, Inc., Phanes Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Virginia · View every site in Fairfax
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT has 119 clinical trials on record, with 92 currently active. Their work covers KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant Colorectal Cancer (CRC).
NEXT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.